Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02347176
Brief Title: Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis (D2213C00001)

First Submitted : January 5, 2015
First Submitted that Met QC Criteria : January 26, 2015
First Posted : January 27, 2015 (Estimate)

Results First Submitted : May 11, 2017
Results First Submitted that Met QC Criteria : May 11, 2017
Results First Posted : June 7, 2017

Certification/Extension First Submitted : February 14, 2017
Certification/Extension First Submitted that Met QC Criteria : March 20, 2017
Certification/Extension First Posted : March 21, 2017

Last Update Submitted that Met QC Criteria : April 24, 2018
Last Update Posted : May 23, 2018